Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

235
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Tonsillitis II: Management01:26

Tonsillitis II: Management

513
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
513
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.8K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.8K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

607
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
607

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Providing an Optimized and emPowered Pregnancy for You (P<sup>3</sup>OPPY) Acceptability and Feasibility Pilot Trial.

American journal of obstetrics & gynecology MFM·2026
Same author

Neonatal Inflammatory Profiles Associated With Perinatally Acquired Hepatitis C Viral Infection.

The Pediatric infectious disease journal·2026
Same author

Corrigendum to 'Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in Pregnancy: Updated Guidelines' [American Journal of Obstetrics and Gynecology 230/4 (2024) B2-B11].

American journal of obstetrics and gynecology·2026
Same author

A model to predict red blood cell transfusion during/after cesarean delivery.

Pregnancy (Hoboken, N.J.)·2026
Same author

Atherosclerotic cardiovascular disease (ASCVD) biomarkers 5-10 years after a hypertensive disorder of pregnancy.

Pregnancy hypertension·2026
Same author

Maternal cytomegalovirus serology results by geographic region in a large multicenter United States study.

The Journal of infectious diseases·2026

Related Experiment Video

Updated: Mar 14, 2026

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

4.5K

Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.

Alan T N Tita1, Jeff M Szychowski1, Kim Boggess1

  • 1From the Departments of Obstetrics and Gynecology (A.T.N.T., J.M.S., W.A.), Biostatistics (J.M.S., G.C.), and Pediatrics (N.A.), University of Alabama at Birmingham, Birmingham; the Departments of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, Chapel Hill (K.B.), and Mission Hospital, Asheville (K.L.) - both in North Carolina; the University of Texas Medical Branch, Galveston (G.S.), and the University of Texas Health Sciences Center, Houston (A.A.); Ochsner Health System, New Orleans (S.L.); the University of Utah (E.C., S.E.) and Intermountain Health Care (E.C., S.E.), Salt Lake City; Columbia University, New York (K.C., R.W.); and the University of Mississippi, Jackson (M.O.).

The New England Journal of Medicine
|September 30, 2016
PubMed
Summary
This summary is machine-generated.

Adding azithromycin to standard antibiotic prophylaxis significantly reduced postoperative infections in women undergoing nonelective cesarean delivery. This extended-spectrum approach improved safety and lowered infection rates compared to placebo.

More Related Videos

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

6.8K
External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
06:28

Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia

Published on: May 27, 2022

4.5K
Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

6.8K
External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Postoperative infections are a significant concern following cesarean delivery.
  • Standard antibiotic prophylaxis may not fully prevent all infections.
  • Evaluating extended-spectrum prophylaxis is crucial for improving maternal outcomes.

Purpose of the Study:

  • To assess the efficacy and safety of azithromycin as an adjunct to standard antibiotic prophylaxis for nonelective cesarean sections.
  • To determine if azithromycin reduces the incidence of postpartum infections.
  • To compare infection rates between azithromycin and placebo groups.

Main Methods:

  • A multicenter randomized controlled trial involving 2013 women undergoing nonelective cesarean delivery.
  • Participants received either intravenous azithromycin or a placebo, in addition to standard antibiotic prophylaxis.
  • The primary outcome measured was a composite of endometritis, wound infection, or other infection within six weeks postpartum.

Main Results:

  • Azithromycin significantly reduced the primary composite outcome of postoperative infection (6.1% vs. 12.0%, P<0.001).
  • Lower rates of endometritis and wound infection were observed in the azithromycin group.
  • Serious maternal adverse events were also lower in the azithromycin group (1.5% vs. 2.9%, P=0.03).

Conclusions:

  • Adjunctive azithromycin in extended-spectrum prophylaxis is effective in reducing postoperative infections after nonelective cesarean delivery.
  • The addition of azithromycin to standard prophylaxis enhances patient safety.
  • Further research may explore optimal antibiotic regimens for cesarean prophylaxis.